Impact BioMedical, INC. (IBO) Operating cash flow 2022–2025
Impact BioMedical, INC. (IBO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.9MFY2025 · since FY2022: -$2.2M → -$1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.9M | +33.8% |
| FY2024 | -$2.9M | -0.1% |
| FY2023 | -$2.9M | -27.2% |
| FY2022 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice